These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 11829081

  • 1. Therapies to improve bone mineral density and reduce the risk of fracture: clinical trial results.
    Watts NB.
    J Reprod Med; 2002 Jan; 47(1 Suppl):82-92. PubMed ID: 11829081
    [Abstract] [Full Text] [Related]

  • 2. [Therapeutic concepts in the treatment of postmenopausal osteoporosis].
    Leidig-Bruckner G, Ziegler R.
    Ther Umsch; 1994 Nov; 51(11):737-47. PubMed ID: 7839332
    [Abstract] [Full Text] [Related]

  • 3. Bone mineral density thresholds for pharmacological intervention to prevent fractures.
    Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, Berger ML.
    Arch Intern Med; 2004 May 24; 164(10):1108-12. PubMed ID: 15159268
    [Abstract] [Full Text] [Related]

  • 4. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr 24; 17(94):68-72. PubMed ID: 18536138
    [Abstract] [Full Text] [Related]

  • 5. Teriparatide: new preparation. Osteoporosis: less well evaluated than alendronic acid.
    Prescrire Int; 2005 Feb 24; 14(75):5-9. PubMed ID: 15747448
    [Abstract] [Full Text] [Related]

  • 6. Treatment of osteoporosis: combination therapies.
    Simon JA, Mack CJ.
    Int J Fertil Womens Med; 2003 Feb 24; 48(3):127-31; discussion 137-8. PubMed ID: 12839144
    [Abstract] [Full Text] [Related]

  • 7. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG.
    CMAJ; 1996 Oct 01; 155(7):929-34. PubMed ID: 8837542
    [Abstract] [Full Text] [Related]

  • 8. Antiresorptive treatment of postmenopausal osteoporosis: review of randomized clinical studies and rationale for the Evista alendronate comparison (EVA) trial.
    Lufkin EG, Sarkar S, Kulkarni PM, Ciaccia AV, Siddhanti S, Stock J, Plouffe L.
    Curr Med Res Opin; 2004 Mar 01; 20(3):351-7. PubMed ID: 15025844
    [Abstract] [Full Text] [Related]

  • 9. Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada.
    CMAJ; 1996 Oct 15; 155(8):1113-33. PubMed ID: 8873639
    [Abstract] [Full Text] [Related]

  • 10. Management of osteoporosis due to ovarian failure.
    Eastell R.
    Med Pediatr Oncol; 2003 Sep 15; 41(3):222-7. PubMed ID: 12868123
    [Abstract] [Full Text] [Related]

  • 11. A review of combination regimens for osteoporosis--prevention and treatment.
    Miller E, Kalin MF.
    Int J Fertil Womens Med; 2002 Sep 15; 47(5):198-204. PubMed ID: 12469706
    [Abstract] [Full Text] [Related]

  • 12. [Hormone replacement therapy and its derivatives in the prevention and treatment of osteoporosis].
    Lamy O, Krieg MA.
    Rev Med Suisse Romande; 2002 Aug 15; 122(8):377-81. PubMed ID: 12357730
    [Abstract] [Full Text] [Related]

  • 13. Clinical inquiries. What is the best approach to prevention and treatment of osteoporosis?
    Schwartz K, Chang SI.
    J Fam Pract; 2001 Dec 15; 50(12):1024-5. PubMed ID: 11742601
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacologic prevention of osteoporotic fractures.
    Zizic TM.
    Am Fam Physician; 2004 Oct 01; 70(7):1293-300. PubMed ID: 15508540
    [Abstract] [Full Text] [Related]

  • 15. 7: Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual's absolute risk of fracture.
    Seeman E, Eisman JA.
    Med J Aust; 2004 Mar 15; 180(6):298-303. PubMed ID: 15012571
    [Abstract] [Full Text] [Related]

  • 16. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP.
    Arch Intern Med; 2003 Oct 13; 163(18):2237-46. PubMed ID: 14557222
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Drug insight: Existing and emerging therapies for osteoporosis.
    Mulder JE, Kolatkar NS, LeBoff MS.
    Nat Clin Pract Endocrinol Metab; 2006 Dec 13; 2(12):670-80. PubMed ID: 17143314
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009].
    Dimai HP, Pietschmann P, Resch H, Preisinger E, Fahrleitner-Pammer A, Dobnig H, Klaushofer K, Austrian Society for Bone and Mineral Research (AuSBMR).
    Wien Med Wochenschr Suppl; 2009 Dec 13; (122):1-34. PubMed ID: 19484202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.